LSKL(a)

CAS No. 283609-79-0

LSKL(a) ( —— )

Catalog No. M20897 CAS No. 283609-79-0

LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 In Stock
5MG 73 In Stock
10MG 118 In Stock
25MG 220 In Stock
50MG 330 In Stock
100MG 495 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LSKL(a)
  • Note
    Research use only not for human use.
  • Brief Description
    LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
  • Description
    LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TGFβ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    283609-79-0
  • Formula Weight
    458.6
  • Molecular Formula
    C21H42N6O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (218.05 mM)
  • SMILES
    CC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liao F Li G Yuan W.et al.LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-β1 signaling activity following subarachnoid hemorrhage in rats.Exp Ther Med. 2016 Oct;12(4):2537-2543.
molnova catalog
related products
  • CORM-3

    CORM-3 is a water-soluble carbon monoxide-releasing molecule with anti-inflammatory and cardioprotective activity.

  • ADA

    ADA is a biological buffer which can serve as a chelator.

  • WYE-687

    WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(T308).